To view the PDF file, sign up for a MySharenet subscription.

APN - Aspen Pharmacare Holdings Limited - Trading statement

Release Date: 21/02/2012 09:05
Code(s): APN
Wrap Text

APN - Aspen Pharmacare Holdings Limited - Trading statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN & ISIN: ZAE000066692 ("Aspen") Trading statement Aspen shareholders are hereby advised that earnings per share, for the 6 months ended 31 December 2011, are expected to exceed those reported in the comparative period, ended 31 December 2010, by 24% to 30%. The growth in earnings per share has benefited from the disposal of the discontinued businesses and products. Headline earnings per share and diluted normalised headline earnings per share from continuing operations, adjusted for transaction and restructure costs are both expected to exceed those of the comparative period by 17% to 23%. The financial results on which this trading announcement is based have not been reviewed or reported on by Aspen`s external auditors. Aspen`s interim results are scheduled to be published on SENS on 7 March 2012. Woodmead 21 February 2012 Sponsor: Investec Bank Limited Date: 21/02/2012 09:05:11 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story